Donatella Conconi

16PUBLICATIONS
33CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersFoetal development and medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 11, 2025
TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy.

Sara Bonomo, Roberto Giovannoni, Marialuisa Lavitrano

|Jan 25, 2025
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases.

Raya Kh Yashooa, Elisa Duranti, Donatella Conconi

|Nov 27, 2024
Prognostic Relevance of Copy Number Losses in Ovarian Cancer.

Andrea Jemma, Alessandra Ardizzoia, Serena Redaelli

|Aug 29, 2024
Cytogenetically Balanced Reciprocal Translocation Could Hide Molecular Genomic Unbalances: Implications for Foetal Phenotype Correlation.

Nicoletta Villa, Serena Redaelli, Stefania Farina

|Mar 13, 2024
Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells.

Martina Giambra, Andrea Di Cristofori, Francesca Raimondo

|Sep 28, 2023
Evaluating [<sup>18</sup>F]FDG and [<sup>18</sup>F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models.

Paolo Rainone, Silvia Valtorta, Chiara Villa

Pageof 3

Frequent Collaborators

14 joint publications

Marialuisa Lavitrano

11 joint publications

Angela Bentivegna

9 joint publications

Serena Redaelli

3 joint publications

Nicoletta Villa